查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1372939

奈米孔定序市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、按核苷酸定序、按类型、按奈米孔类型、按应用、按最终用户、按地区和竞争细分

Nanopore Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Nucleotide Sequenced, By Type, By Type of Nanopore, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 173 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

到2022 年，全球奈米孔定序市场价值为2.9131 亿美元，预计到2028 年，预测期内将出现令人印象深刻的成长，复合年增长率为17.57%。奈米孔定序是用于生物聚合物定序的第三代技术，特别是多核苷酸，例如DNA 或 RNA 以及其他成分。这种先进的方法能够分析单分子 DNA 或 RNA，无需对样本进行 PCR 扩增或化学标记。奈米孔定序凭藉其具有成本效益的基因分型、增强的测试流动性以及快速样品处理和即时结果的潜力，处于定序技术的前沿。透过测量分子通过奈米孔时电流的波动，可以准确识别给定核酸的序列。作为尖端的第四代技术，奈米孔定序涉及单一 DNA 或 RNA 链通过称为奈米孔的微小蛋白质通道。这些奈米孔嵌入电阻膜内，引起离子电流的变化，促进碱基序列和修饰的确定。这种机制为基因组学研究提供了宝贵的见解。

主要市场驱动因素

各种研究应用对 DNA 定序的需求不断增加

市场概况
预测期 2024-2028
2022 年市场规模 2.9131亿美元
2028 年市场规模 74249万美元
2023-2028 年复合年增长率 17.57%
成长最快的细分市场 耗材
最大的市场 北美洲

各种研究应用对 DNA 定序的需求不断增加，推动了对奈米孔定序技术的需求激增。奈米孔定序是一种革命性的方法，可以对 DNA、RNA 和其他生物分子进行即时、单分子分析。其多功能性和独特优势使其在基因组学、遗传学等领域越来越受欢迎。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球奈米孔定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品（消耗品与仪器）
    • 透过核苷酸定序（DNA vs RNA）
    • 按类型（直流定序、合成 DNA 和水平隧道电流定序、光学读取技术定序、核酸外切酶定序）
    • 依奈米孔类型（固态、生物、混合）
    • 按应用（人类遗传学、临床研究、植物研究、微生物学、动物研究）
    • 按最终用户（生物技术公司、临床实验室、学术和研究机构）
    • 按地区
    • 按公司划分 (2022)
  • 市场地图

第 6 章：北美奈米孔定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 透过核苷酸定序
    • 按类型
    • 依奈米孔类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲奈米孔定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 透过核苷酸定序
    • 按类型
    • 依奈米孔类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太地区奈米孔定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 透过核苷酸定序
    • 按类型
    • 依奈米孔类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲奈米孔定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 透过核苷酸定序
    • 按类型
    • 依奈米孔类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东与非洲奈米孔定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 透过核苷酸定序
    • 按类型
    • 依奈米孔类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非奈米孔定序
    • 沙乌地阿拉伯奈米孔定序
    • 阿联酋奈米孔定序

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球奈米孔定序市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 服务内容
  • 最近的发展
  • 主要人员
  • SWOT分析
    • Oxford Nanopore Technologies plc
    • Illumnia, Inc.
    • F. Hoffmann-La Roche AG
    • 10X Genomics, Inc.
    • Agilent Technolgies, Inc.
    • NabSys, Inc.
    • Sequenom, Inc.
    • Quantapore, Inc.
    • InanoBio Inc.
    • Electronic BioSciences, Inc.

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 7677

lobal Nanopore Sequencing Market has valued at USD 291.31 Million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 17.57% through 2028. Nanopore sequencing is a third-generation technique utilized for the sequencing of biopolymers, specifically polynucleotides such as DNA or RNA, along with other components. This advanced method enables the analysis of single molecule DNA or RNA without the need for PCR amplification or chemical labeling of the sample. With its potential for cost-effective genotyping, enhanced mobility for testing, and rapid sample processing with real-time results, nanopore sequencing stands at the forefront of sequencing technologies. By measuring fluctuations in electric current as the molecule passes through a nanopore, the sequence of the given nucleic acid can be accurately identified. As a cutting-edge fourth-generation technology, nanopore sequencing involves the passage of individual DNA or RNA strands through minuscule protein channels called nanopores. Embedded within an electrically resistant membrane, these nanopores induce alterations in ion current, facilitating the determination of base sequences and modifications. This mechanism offers invaluable insights in genomics research.

Key Market Drivers

Increase In Demand for DNA Sequencing For Various Application For Research

Market Overview
Forecast Period2024-2028
Market Size 2022USD 291.31 Million
Market Size 2028USD 742.49 Million
CAGR 2023-202817.57%
Fastest Growing SegmentConsumables
Largest MarketNorth America

The increase in demand for DNA sequencing across various research applications is driving a surge in the demand for nanopore sequencing technology. Nanopore sequencing is a revolutionary method that allows for the real-time, single-molecule analysis of DNA, RNA, and other biomolecules. Its versatility and unique advantages make it increasingly popular in the fields of genomics, genetics, and beyond.

One of the primary drivers for the growing demand of nanopore sequencing is its broad range of applications. Researchers are using nanopore sequencing for diverse purposes, including genome sequencing, metagenomics, epigenomics, transcriptomics, and more. Its ability to directly read long DNA strands and detect base modifications in real-time offers a comprehensive view of genetic information, enabling scientists to address complex biological questions. Furthermore, nanopore sequencing is known for its portability and rapid turnaround time. Compact nanopore sequencers, such as those offered by Oxford Nanopore Technologies, allow researchers to perform sequencing experiments in a variety of settings, including remote or field-based environments. This feature has opened up new possibilities for on-site genomics research, infectious disease monitoring, and environmental analysis.

Additionally, the continuous advancement of nanopore sequencing technology is expanding its applications further. Improved accuracy, longer read lengths, and lower sequencing costs are making nanopore sequencing more attractive to researchers. As the technology matures and becomes more cost-effective, it is increasingly integrated into research pipelines and clinical diagnostics. The surge in demand for DNA sequencing across diverse research areas is propelling the adoption of nanopore sequencing technology. Its versatility, portability, and continuous improvements make it a valuable tool for scientists seeking comprehensive genetic insights and real-time data, contributing to groundbreaking discoveries and advancements in various fields of study. As nanopore sequencing continues to evolve, its role in genomics and beyond is likely to expand even further, driving sustained demand for this innovative technology.

Partnerships and Acquisition to Boost Adoption and Co-Develop Advanced Solutions

The rapidly growing nanopore sequencing market has witnessed a multitude of strategic partnerships and acquisitions by key market players. These collaborative endeavors, driven by a shared vision, not only aim to amplify the adoption of this cutting-edge technology for clinical applications but also to collectively foster the development of state-of-the-art sequencing platforms that will truly revolutionize the field.

By leveraging the expertise, knowledge, and resources of multiple stakeholders, these alliances seek to unlock the full potential of nanopore sequencing. Through collaborative efforts, advancements in genomic research and precision medicine can be propelled to unprecedented levels, paving the way for groundbreaking discoveries and personalized treatments.

The significance of these strategic alliances and acquisitions within the market cannot be overstated. They serve as a testament to the immense potential and transformative power of nanopore sequencing in shaping the future of healthcare and personalized medicine. These partnerships lay a solid foundation for continued innovation, pushing the boundaries of what is possible and opening new horizons in the field of genomics.

As the nanopore sequencing market continues to evolve, these strategic alliances will play a crucial role in driving advancements, accelerating research, and ultimately improving patient outcomes. The collaborative efforts of industry leaders underscore the commitment to innovation and the shared goal of revolutionizing healthcare through the power of nanopore sequencing technology.

Introduction Of Internet of Things

The introduction of Internet of Things (IoT) has greatly benefited nanopore technology. With the ability to easily connect sequencers to other technical systems, healthcare professionals can now monitor DNA samples on shared cloud computing labs. This advancement is anticipated to not only aid in the growth of the market in the forecast period but also revolutionize genomics by expanding its applications to a wider range of needs. The convergence of ultrafast nanopore sequencing, biosensors, cloud computing, computational intelligence algorithms, and other related technologies has paved the way for new possibilities in genomics research.

Moreover, nanopore-based sequencers, as the fourth-generation DNA sequencing technology, hold immense potential. They offer the ability to quickly and reliably sequence the entire human genome for less than USD1000, and possibly even less than USD100. The utilization of single-molecule techniques by this technology also enables further study of the intricate interactions between DNA and proteins, as well as between different proteins. This enhanced understanding of molecular interactions opens up new opportunities for advancements in various fields, including medicine, biotechnology, and beyond.

Increase In R&D On Nanopore sequencing

The increase in research and development (R&D) efforts focused on nanopore sequencing is significantly driving up the demand for nanopore sequencing. Nanopore sequencing, a cutting-edge method in genomics, relies on the use of nanopores, tiny openings at the nanoscale level, to analyze individual DNA or RNA molecules as they pass through these pores. Intensive R&D investments are leading to continuous advancements in nanopore sequencing. Researchers are working to refine the design, materials, and manufacturing processes of nanopore sequencing devices. These improvements result in more reliable and accurate sequencing platforms, which in turn boost the appeal of nanopore sequencing for various applications. R&D efforts are driving down the cost of producing nanopore sequencing devices and reagents. As manufacturing processes become more efficient and scalable, the overall cost of nanopore sequencing decreases, making it more accessible to a wider range of researchers and laboratories.

Longer read lengths are a crucial aspect of sequencing technology, as they enable researchers to decipher complex genomic regions and perform de novo sequencing more effectively. R&D endeavors are extending the read lengths achievable with nanopore sequencing, further enhancing its utility in genomics research. Ongoing research into nanopore sequencing is uncovering new applications beyond genomics. These include epigenetics, structural biology, and the analysis of various biomolecules, such as proteins and RNA. As the range of applications widens, the demand for nanopore sequencing grows across diverse scientific disciplines. R&D is driving the development of smaller and more portable nanopore sequencing devices. These compact instruments can be utilized in various settings, including remote or point-of-care environments, broadening the potential use cases for nanopore sequencing.

Key Market Challenges

Higher Error Rate and Experimental Barriers

While nanopore sequencing technology offers numerous advantages, it also comes with certain limitations. These limitations include a higher error rate and the requirement of larger amounts of nucleic acid material compared to other sequencing technologies like sequencing by synthesis (SBS).

Researchers are actively working on substantial improvements to reduce the error rate and ensure high data accuracy. These efforts involve optimizing molecule translocation ratcheting, achieving context-independent and high-quality raw signals, and developing base-calling methods using advanced computational techniques like machine learning.

Currently, nanopore sequencing requires a few micrograms of DNA and hundreds of nanograms of RNA, which can be an experimental barrier. Reducing the sample size requirement would greatly benefit nanopore sequencing in various biomedical studies where genetic material is limited. Additionally, integrating and automating DNA/RNA extraction, library preparation, and loading systems would be highly beneficial for generating sequencing data without the need for specific training. The development of robust bioinformatics software that enables cloud storage, computing, and real-time analysis will further drive the adoption of nanopore sequencing across different applications and settings.

Despite the experimental challenges, the nanopore sequencing market is expected to grow significantly due to rapid advancements in this technology. Ongoing improvements in terms of read length, throughput, and accuracy aim to facilitate research and clinical applications such as rapid clinical diagnosis and outbreak surveillance.

Issues In Maintaining the Integration and Structure of The Nucleotide

Issues in maintaining the integration and structure of nucleotides are posing challenges that may potentially impact the demand for nanopore sequencing technology. While nanopore sequencing has shown immense promise in various genomics applications, it is not without limitations, and certain challenges associated with the preservation of nucleotide integrity are worth considering. Nanopore sequencing requires intact DNA or RNA molecules to pass through the nanopores for accurate sequencing. However, biological samples, especially those from older or degraded specimens, can suffer from DNA damage and fragmentation. Maintaining the structural integrity of nucleotides becomes critical in such cases, as damaged or fragmented molecules can lead to sequencing errors and reduced data quality.

Nucleotide modifications, such as methylation or hydroxymethylation, play crucial roles in gene regulation and epigenetics. Nanopore sequencing has the potential to detect these modifications directly, but maintaining the structural integrity of nucleotides during sequencing is essential for preserving this valuable epigenetic information accurately. Ongoing research and development efforts are addressing many of the issues related to maintaining nucleotide integrity in nanopore sequencing. Improved library preparation protocols, enhanced nanopore chemistry, and software advancements are gradually mitigating some of these concerns. However, it is essential for users to carefully assess their specific research needs and the quality of their nucleotide samples when considering the adoption of nanopore sequencing technology, particularly in applications where nucleotide structure is critical to the research outcome.

Key Market Trends

Use Of Nanopore sequencing for Fourth Generation DNA Sequencing

The surge in the use of nanopore sequencing for fourth-generation DNA sequencing is anticipated to offer a highly lucrative opportunity for market growth in the coming years. Nanopore-based sequencers, as the fourth-generation DNA sequencing technology, have shown tremendous potential in quickly and reliably sequencing the entire human genome for less than USD 1000, and possibly even less than USD 100. This significant decrease in the cost of nanopore sequencing for analyzing different types of sequences is expected to capture the attention of a majority of healthcare professionals, including researchers, clinicians, and geneticists. With the ability to provide fast and accurate DNA sequencing results at a fraction of the cost of traditional methods, nanopore sequencing have the potential to revolutionize the field of genomics. This advancement will not only make DNA sequencing more accessible and affordable for a wider range of applications but also enable new discoveries and advancements in personalized medicine, genetic research, and disease diagnosis. The integration of nanopore sequencing into healthcare settings has the potential to transform the way we understand and treat genetic diseases, paving the way for more targeted and effective therapies. As the adoption of nanopore-based sequencers continues to grow, the market is poised for significant expansion, presenting exciting opportunities for companies operating in the genomics and biotechnology sectors.

Miniaturization and Portability

Nanopore sequencers will continue to become smaller and more portable. Handheld or field-deployable devices will enable on-site sequencing in remote locations, disaster response scenarios, and point-of-care applications. Researchers and engineers are working to reduce the size and weight of nanopore sequencing devices. This involves shrinking the electronics, improving heat management, and optimizing power consumption to create more compact instruments. Field-deployable devices need to withstand harsh conditions, including temperature variations, humidity, and physical shocks. Robust construction and ruggedized designs will be essential to ensure the reliability of these devices.

Simplified sample preparation techniques will be designed to minimize the need for extensive laboratory equipment and expertise. These techniques will be tailored to the unique requirements of portable nanopore sequencers. Handheld sequencers will be part of a broader ecosystem that includes field laboratories equipped with portable DNA extraction and sample preparation systems. This integration ensures a seamless workflow from sample collection to sequencing in remote locations. Portable nanopore sequencers will be designed with specific field applications in mind, such as monitoring infectious disease outbreaks, studying environmental microbiomes, or performing rapid diagnostics in point-of-care settings.

Segmental Insights

Product Insights

Based on the comprehensive product analysis, it is evident that the consumables segment is the primary contributor to revenue and is projected to experience substantial growth throughout the entire forecast period. This can be attributed to the notable surge in the utilization of consumables across a wide range of procedures, including DNA sequencing and RNA sequencing, which are crucial in advancing scientific research and innovation in the field of genomics.

Furthermore, the rising adoption of consumables in previously unexplored applications, such as the sequencing of novel viruses, is expected to further bolster the segment's market share. This expansion into new territories highlights the adaptability and versatility of consumables, showcasing their vital role in addressing emerging challenges and exploring new frontiers in genomics. As the demand for advanced genetic analysis continues to increase, the significance of consumables cannot be overstated. They serve as the backbone of scientific advancements, facilitating breakthrough discoveries and enabling researchers to unravel the complexities of the genetic code. With their pivotal role in enhancing the accuracy, efficiency, and reliability of genomics research, consumables are poised to shape the future of scientific exploration and contribute to the ongoing progress in the field.

End User Insights

Based on end user, the global market was predominantly led by Academic & Research Institutes, a trend that is expected to continue in the foreseeable future. This dominance can be attributed to the surging demand for nanopore sequencing in research institutes, which are increasingly recognized for their immense potential to revolutionize various fields of study. The adoption of nanopore sequencing by these institutes has not only facilitated ground-breaking research but has also paved the way for remarkable discoveries, further solidifying their position as key drivers of innovation in the market. With their unwavering commitment to pushing the boundaries of scientific exploration, Academic & Research Institutes are poised to shape the future of technological advancements and continue to fuel the progress of the market.

Regional Insights

North America is well-positioned to dominate the market during the forecast period. This is primarily due to the increasing demand for nanopore sequencing, driven by the rising incidences of viral diseases in the region. Moreover, the presence of major key players in North America further strengthens its market position. Additionally, the growing targeted patient population and higher healthcare expenditure contribute to the region's market growth. The favorable government policies for research in nanopore sequencing also act as a catalyst for market expansion in the coming years.

Furthermore, Asia-Pacific, South America, and the Middle East and Africa (MEA) present lucrative opportunities for key players in the nanopore technology market. The increasing number of hospitals equipped with nanopore technology modalities and the significant utilization of nanopore sequencing in these regions contribute to their market potential. Moreover, the market is anticipated to witness growth in the next few years, fueled by the rising geriatric population, which is more susceptible to viral diseases.

The market outlook for nanopore sequencing is promising, with North America leading the way and other regions offering significant growth opportunities. The combination of increasing demand, favorable government policies, and the rising geriatric population sets the stage for continued market expansion in the coming years.

Key Market Players

Oxford Nanopore Technologies plc

Illumnia, Inc.

F. Hoffmann-La Roche AG

10X Genomics, Inc.

Agilent Technolgies, Inc.

NabSys, Inc.

Sequenom, Inc.

Quantapore, Inc.

InanoBio Inc.

Electronic BioSciences, Inc.

Report Scope:

In this report, the Global Nanopore Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nanopore Sequencing Market, By Product:

  • Consumables
  • Instruments

Nanopore Sequencing Market, By Nucleotide Sequenced:

  • DNA
  • RNA

Nanopore Sequencing Market, By Type:

  • Direct Current Sequencing
  • Synthetic DNA and Horizontal Tunnelling Current Sequencing
  • Optical Reading Techniques Sequencing
  • Exonuclease Sequencing

Nanopore Sequencing Market, By Type of Nanopore:

  • Solid State
  • Biological
  • Hybrid

Nanopore Sequencing Market, By Type of Application:

  • Human Genetics
  • Clinical Research
  • Plant Research
  • Microbiology
  • Animal Research

Nanopore Sequencing Market, By Type of End User:

  • Biotechnology Companies
  • Clinical Laboratories
  • Academic & Research Institutes

Nanopore Sequencing Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Nanopore Sequencing Market.

Available Customizations:

  • Global Nanopore Sequencing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nanopore Sequencing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables v/s Instruments)
    • 5.2.2. By Nucleotide Sequenced (DNA v/s RNA)
    • 5.2.3. By Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing)
    • 5.2.4. By Type of Nanopore (Solid State, Biological, Hybrid)
    • 5.2.5. By Application (Human Genetics, Clinical Research, Plant Research, Microbiology, Animal Research)
    • 5.2.6. By End User (Biotechnology Companies, Clinical Laboratories, Academic & Research Institutes)
    • 5.2.7. By Region
    • 5.2.8. By Company (2022)
  • 5.3. Market Map

6. North America Nanopore Sequencing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Nucleotide Sequenced
    • 6.2.3. By Type
    • 6.2.4. By Type of Nanopore
    • 6.2.5. By Application
    • 6.2.6. By End User
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Nanopore Sequencing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Nucleotide Sequenced
        • 6.3.1.2.3. By Type
        • 6.3.1.2.4. By Type of Nanopore
        • 6.3.1.2.5. By Application
        • 6.3.1.2.6. By End User
    • 6.3.2. Canada Nanopore Sequencing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Nucleotide Sequenced
        • 6.3.2.2.3. By Type
        • 6.3.2.2.4. By Type of Nanopore
        • 6.3.2.2.5. By Application
        • 6.3.2.2.6. By End User
    • 6.3.3. Mexico Nanopore Sequencing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Nucleotide Sequenced
        • 6.3.3.2.3. By Type
        • 6.3.3.2.4. By Type of Nanopore
        • 6.3.3.2.5. By Application
        • 6.3.3.2.6. By End User

7. Europe Nanopore Sequencing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Nucleotide Sequenced
    • 7.2.3. By Type
    • 7.2.4. By Type of Nanopore
    • 7.2.5. By Application
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Nanopore Sequencing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Nucleotide Sequenced
        • 7.3.1.2.3. By Type
        • 7.3.1.2.4. By Type of Nanopore
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By End User
    • 7.3.2. United Kingdom Nanopore Sequencing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Nucleotide Sequenced
        • 7.3.2.2.3. By Type
        • 7.3.2.2.4. By Type of Nanopore
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By End User
    • 7.3.3. Italy Nanopore Sequencing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Nucleotide Sequenced
        • 7.3.3.2.3. By Type
        • 7.3.3.2.4. By Type of Nanopore
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By End User
    • 7.3.4. France Nanopore Sequencing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Nucleotide Sequenced
        • 7.3.4.2.3. By Type
        • 7.3.4.2.4. By Type of Nanopore
        • 7.3.4.2.5. By Application
        • 7.3.4.2.6. By End User
    • 7.3.5. Spain Nanopore Sequencing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Nucleotide Sequenced
        • 7.3.5.2.3. By Type
        • 7.3.5.2.4. By Type of Nanopore
        • 7.3.5.2.5. By Application
        • 7.3.5.2.6. By End User

8. Asia-Pacific Nanopore Sequencing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Nucleotide Sequenced
    • 8.2.3. By Type
    • 8.2.4. By Type of Nanopore
    • 8.2.5. By Application
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Nanopore Sequencing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Nucleotide Sequenced
        • 8.3.1.2.3. By Type
        • 8.3.1.2.4. By Type of Nanopore
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By End User
    • 8.3.2. India Nanopore Sequencing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Nucleotide Sequenced
        • 8.3.2.2.3. By Type
        • 8.3.2.2.4. By Type of Nanopore
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By End User
    • 8.3.3. Japan Nanopore Sequencing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Nucleotide Sequenced
        • 8.3.3.2.3. By Type
        • 8.3.3.2.4. By Type of Nanopore
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By End User
    • 8.3.4. South Korea Nanopore Sequencing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Nucleotide Sequenced
        • 8.3.4.2.3. By Type
        • 8.3.4.2.4. By Type of Nanopore
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By End User
    • 8.3.5. Australia Nanopore Sequencing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Nucleotide Sequenced
        • 8.3.5.2.3. By Type
        • 8.3.5.2.4. By Type of Nanopore
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By End User

9. South America Nanopore Sequencing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Nucleotide Sequenced
    • 9.2.3. By Type
    • 9.2.4. By Type of Nanopore
    • 9.2.5. By Application
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Nanopore Sequencing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Nucleotide Sequenced
        • 9.3.1.2.3. By Type
        • 9.3.1.2.4. By Type of Nanopore
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By End User
    • 9.3.2. Argentina Nanopore Sequencing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Nucleotide Sequenced
        • 9.3.2.2.3. By Type
        • 9.3.2.2.4. By Type of Nanopore
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By End User
    • 9.3.3. Colombia Nanopore Sequencing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Nucleotide Sequenced
        • 9.3.3.2.3. By Type
        • 9.3.3.2.4. By Type of Nanopore
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By End User

10. Middle East and Africa Nanopore Sequencing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Nucleotide Sequenced
    • 10.2.3. By Type
    • 10.2.4. By Type of Nanopore
    • 10.2.5. By Application
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Nanopore Sequencing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Nucleotide Sequenced
        • 10.3.1.2.3. By Type
        • 10.3.1.2.4. By Type of Nanopore
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By End User
    • 10.3.2. Saudi Arabia Nanopore Sequencing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Nucleotide Sequenced
        • 10.3.2.2.3. By Type
        • 10.3.2.2.4. By Type of Nanopore
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By End User
    • 10.3.3. UAE Nanopore Sequencing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Nucleotide Sequenced
        • 10.3.3.2.3. By Type
        • 10.3.3.2.4. By Type of Nanopore
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Nanopore Sequencing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Oxford Nanopore Technologies plc
    • 15.5.2. Illumnia, Inc.
    • 15.5.3. F. Hoffmann-La Roche AG
    • 15.5.4. 10X Genomics, Inc.
    • 15.5.5. Agilent Technolgies, Inc.
    • 15.5.6. NabSys, Inc.
    • 15.5.7. Sequenom, Inc.
    • 15.5.8. Quantapore, Inc.
    • 15.5.9. InanoBio Inc.
    • 15.5.10. Electronic BioSciences, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer